首页> 外文期刊>Schizophrenia research >Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
【24h】

Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.

机译:用氯氮平或奥氮平治疗的精神分裂症患者在心理理论上的表现要优于使用利培酮或典型抗精神病药物治疗的精神分裂症患者。

获取原文
获取原文并翻译 | 示例
           

摘要

Theory of mind (ToM), the ability to attribute mental states to others, is associated with medial prefrontal cortical (mPFC) activity and is impaired in schizophrenia. Olanzapine or clozapine but not typical antipsychotics or risperidone preferentially affect c-fos expression in mPFC in animals. We tested the hypothesis that schizophrenic patients treated with different antipsychotics would perform differently on ToM tasks. Groups receiving Typicals (n=23), Clozapine (n=18), Olanzapine (n=20) or Risperidone (n=23) and a Control group of healthy volunteers (n=24) were matched for age, gender, handedness and education. ToM functioning was assessed with picture sequence, second-order belief and faux-pas tests. Schizophrenic groups performed similarly to controls on non-ToM conditions. The Olanzapine and Clozapine groups performed similarly to Controls on ToM tasks. The Typicals and Risperidone groups performed worse than the other groups on ToM tasks. We concluded that ToM performance of schizophrenic patients is influenced by the antipsychotic they are taking. Our results suggest that olanzapine or clozapine but not typicals or risperidone may improve or protect ToM ability.
机译:心理理论(ToM)是将精神状态归因于他人的能力,与内侧前额叶皮层(mPFC)活动相关,并且在精神分裂症中受损。奥氮平或氯氮平对动物的mPFC中的c-fos表达有优先影响,但对典型的抗精神病药或利培酮无影响。我们检验了以下假设:使用不同的抗精神病药治疗的精神分裂症患者在ToM任务上的表现会有所不同。接受典型组(n = 23),氯氮平(n = 18),奥氮平(n = 20)或利培酮(n = 23)的组和健康志愿者对照组(n = 24)的年龄,性别,惯用性和教育。 ToM功能通过图片序列,二阶置信度和仿pas测试进行评估。精神分裂症组的表现与非ToM条件下的对照组相似。奥氮平和氯氮平组的表现与对ToM任务的控制相似。典型组和利培酮组在ToM任务上的表现比其他组差。我们得出的结论是,精神分裂症患者的ToM表现受他们服用的抗精神病药的影响。我们的结果表明,奥氮平或氯氮平但不是典型药物或利培酮可能会改善或保护ToM能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号